Skip to main content

December 2018

 

 

academics

 

Clinical research courses

Applications are invited for Junior Research Fellow at NIMHANS

National Institute of Mental Health and Neuro Sciences is a multidisciplinary Institute for patient care and academic pursuit in the frontier area of Mental Health and Neuro Sciences. The Lunatic Asylum which came into being in the latter part of the 19th Century was renamed as Mental Hospital in 1925 by the erstwhile Government of Mysore. This hospital and All India Institute of Mental Health established in 1954 by Government of India were amalgamated on 27th December 1974, and thus was formed the autonomous National Institute of Mental Health and Neuro Sciences (NIMHANS).

Post : Junior Research Fellow

Walk in interview for M.Pharm, M.Sc in Analytical R&D at Caplin Point Laboratories

Caplin Point Laboratories Ltd generate over US$50 million in revenue annually with a healthy bottom line. We have recently been selected by Forbes Asia magazine as one of the Top 200 best performing companies in Asia, for the second time in a row. Caplin is the only Pharma company in India to be selected in both 2014 and 2015. We have been manufacturing, exporting and distributing our products to Latin America and Africa for the last 16 years and we're already in the Top 5 exporters from India to Latin America over the last few years. We are currently holding over 2000 product licenses in these regions with another 490 in the pipeline.

Job for Scientist in Analytical Development at Novartis

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Scientist - Analytical Development

Walk in interview in API Stores, Warehouse at Macleods Pharmaceuticals

Macleods Pharmaceuticals is a dream come true for a medical doctor, Dr.R.Agarwal, the Managing Director, who had a vision to provide quality health care to humanity. Dr. R. Agarwal incorporated Macleods in 1986 with a mission to spread the wings of health globally. Macleods has a dedicated team of over 5500 personnel who diligently contribute towards the 10 billion (US$ 220 million) turnover of the organization.

Post : Sr. Offiror / Officer - API Stores/Warehouse department at Sarigam Plant

Multiple Job openings at Pharma Industry (REGULATORY Plant) - Srini Pharmacy

REGULATORY PLANT PHARMA - Candidates are required

Researchers at MIT, Draper, and Brigham and Women’s Hospital have designed an ingestible capsule that can be controlled using Bluetooth wireless technology. The capsule, which can be customized to deliver drugs, sense environmental conditions, or both, can reside in the stomach for at least a month, transmitting information and responding to instructions from a user’s smartphone.

STUDY OF HERBAL DRUGS FOR THE TREATMENT OF SEXUAL DYSFUNCTION

{ DOWNLOAD AS PDF }

ABOUT AUTHOR
Nayan Jain*
Mandsaur Institute of Pharmacy,
Mandsaur, MP, India

ABSTRACT
Sexual dysfunction or sexual disorder is difficulty experienced by a couple or an individual during any stage of a normal sexual activity, including physical pleasure, preference, desire, arousal or orgasm. Sexual arousal disorders were previously known as impotence in men and frigidity in women, though these have now been replaced with less judgmental terms. The causes vary considerably but include a possible decrease in the production of normal estrogen in women or testosterone in both men and women. Causes of dysfunction are aging, fatigue, pregnancy, medications or psychiatric conditions, such as depression and anxiety.

Herbal medicines may cure or prevent certain ailments. However, there are very little recorded data available to support the dose, efficacy, side effects and interactions. Because the safety and efficacy of herbal remedies they are likely to be used then synthetic medicines. The amount of active ingredients in herbals may vary among preparations. Thus, standardization of herbal medicines is required.

Protecting patient safety is at the core of the FDA’s mission. All FDA-approved drugs have benefits and risks which must be weighed and balanced by health care providers and patients when making decisions about medical therapy. Our goal is to ensure that the benefits and risks are clearly articulated in drug labeling. That patients and providers have accurate information. And that the benefits outweigh the risks for the intended patient population.

The Global Health Innovative Technology (GHIT) Fund announced a total of 520 million yen (US$ 4.6 million) to support four partnerships to develop new lifesaving drugs and vaccines for malaria, tuberculosis, dengue and leishmaniasis. This includes three new projects and one that will receive continued funding.